The approved product is therapeutically equivalent to the reference
listed drug Klonopin orally disintegrating tablets of Hoffmann-La
Roche, Inc.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-usfda-nod-for-seizure-treatment-drug/articleshow/70019754.cms
Sunday, June 30, 2019
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment